Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HCRTR1 | O43613 | 1/20 | 0.32 |
| ▸ | HCRTR2 | O43614 | 1/20 | 0.32 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.31 |
| ▸ | P2RX7 | Q99572 | 1/20 | 0.31 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.30 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.30 |
| ▸ | GABRA1 | P14867 | 2/20 | 0.30 |
| ▸ | GABRB2 | P47870 | 2/20 | 0.30 |
| ▸ | CYP11B1 | P15538 | 2/20 | 0.30 |
| ▸ | CYP11B2 | P19099 | 2/20 | 0.30 |
| ▸ | LMNA | P02545 | 1/20 | 0.30 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.30 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.30 |
| ▸ | ABCB11 | O95342 | 1/20 | 0.30 |
| ▸ | GABRA2 | P47869 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24966266 | 0.88 | MAPK1 (0.32) | MAPK1CYP1A2CYP3A4GABRA1GABRB2 | |
| SCHEMBL24966185 | 0.86 | NPBWR1 (0.35) | MAPK1CYP1A2CYP3A4GABRA1GABRB2 | |
| SCHEMBL24966712 | 0.80 | BRD4 (0.32) | MAPK1 | |
| SCHEMBL24966080 | 0.79 | BRD4 (0.34) | MAPK1CYP1A2CYP3A4GABRA1GABRB2 | |
| SCHEMBL24966101 | 0.77 | BRD4 (0.39) | MAPK1CYP1A2CYP3A4GABRA1GABRB2 | |
| SCHEMBL22696994 | 0.77 | MAPK1 (0.36) | MAPK1CYP1A2CYP3A4GABRA1GABRB2 | |
| SCHEMBL24966264 | 0.76 | BRD4 (0.34) | MAPK1CYP1A2CYP3A4GABRA1GABRB2 | |
| SCHEMBL22696921 | 0.74 | MAPK1 (0.36) | MAPK1P2RX7CYP1A2CYP3A4GABRA1 | |
| SCHEMBL22696810 | 0.74 | MEN1 (0.33) | MAPK1 | |
| SCHEMBL24966049 | 0.74 | GABRA1 (0.36) | MAPK1CYP1A2CYP3A4GABRA1GABRB2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230026724-A1 | SUBSTITUTED NITROGEN HETEROCYCLIC COMPOUND AND ANESTHETIC EFFECT THEREOF | CHENGDU MFS PHARMA. CO., LTD. (CN) | 2023-01-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230026724-A1 | SUBSTITUTED NITROGEN HETEROCYCLIC COMPOUND AND ANESTHETIC EFFECT THEREOF | CYP21A2, CYP11B1, CYP11B2 | HCRTR1 609/4885HCRTR2 802/4885MAPK1 1577/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.